Yanxing Cai

Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit

Yanxing Cai, Wei Xu, Chenjian Gu et al. · Virologica Sinica · 2020 · 61 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +17

A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases

Jie Zhou, Wei Xu, Zezhong Liu et al. · Acta Pharmaceutica Sinica B · 2021 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses

Qiaoshuai Lan, Chao Wang, Jie Zhou et al. · International Journal of Molecular Sciences · 2021 · 22 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +16

A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses

Yanxing Cai, Wei Xu, Jiayi Tang et al. · Cell & Bioscience · 2021 · 20 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor

Najing Cao, Yanxing Cai, Xin Huang et al. · mBio · 2024 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17